Neurorestorative therapies should therefore be evaluated not only by engraftment or lesion volume but also by their ability to restore metabolic homeostasis across the NVU (Fig
Sidhu GK, Tuan PA, Renault S, Daayf F, Ayele BT (2020) Polyamine-mediated transcriptional regulation of enzymatic antioxidative response to excess soil moisture during early seedling growth in soybean
The REDEFINE 4 trial: the definitive showdown Everything discussed above relies on cross-trial comparisons, which carry inherent limitations
As described in a new paper published in Science , Kvan Birsoy and his colleagues in Rockefellers Laboratory of Metabolic Regulation and Genetics have discovered the first such sensor for an organellespecifically mitochondria, the cells power center
Trial REDEFINE 2 Phase 3 Duration 68 weeks Population (N) 1,206 adults with T2D + obesity/overweight Key Result 13.7% mean weight change vs 3.4% placebo (treatment-policy)
TB-500 (synthetic Thymosin Beta-4 fragment) is studied for its involvement in actin regulation, tissue remodeling, and cellular regeneration signaling